NK:IO
PrivateLast Round
Seed
Oct 23, 2024
Total Funding Raised
$7.4M
Company Overview
NK:IO operates in Healthcare & Life Sciences and is based in London. Its latest recorded funding round was a Seed round in October 2024.
NK:IO is a biotechnology company developing off-the-shelf natural killer (NK) cell therapies for the treatment of solid tumours.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine
Business Model
B2B
Customer Profile
Government Contracts, Services & Consulting
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
NK:IO Comparables
Compare NK:IO with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| CytoImmune Therapeutics | 84% | |
| ONK Therapeutics | 82% | |
| Shanghai Enkai Cell Technology Co., Ltd. | 81% |
For institutional investors. Book with your work email.
NK:IO Funding Rounds
Historical fundraising activity
For institutional investors. Book with your work email.
NK:IO Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Start Codon | Seed |
| Cambridge Angels | Seed |
| Meltwind Advisory | Seed |
| UK Innovation & Science Seed Fund | Seed |
| Cancer Research Horizons | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Nov 8, 2025
Monthly visitors grew 220% MoM, reaching 3.1K.
- May 3, 2025
Monthly visitors increased 133% MoM, reaching 2.3K.
For institutional investors. Book with your work email.
NK:IO Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about NK:IO's valuation, stock price, and market status.
Is NK:IO a public or private company?
NK:IO is a private company.
What is the current stock price of NK:IO?
NK:IO is a private company, so its shares have no public market price. Caplight tracks NK:IO's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is NK:IO worth (valuation)?
Valuation information for NK:IO is not publicly available.
Can I buy NK:IO stock?
NK:IO shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was NK:IO's last funding round?
NK:IO's most recent funding round was Seed on October 23, 2024.
Who are the main investors in NK:IO?
Key investors in NK:IO include UK Innovation & Science Seed Fund, Cancer Research Horizons.
Will NK:IO IPO soon?
No public IPO plans have been announced for NK:IO.
How can I track NK:IO secondary market activity?
Caplight tracks bids, offers, and trades in NK:IO's shares on secondary markets.